Analyytikon kommentti

Embla Medical: Recording of Q1 2026 results presentation

– Michael FriisHead of Equities

Yesterday, Embla Medical’s CEO, Sveinn Sölvason, presented the Q1 2026 results and outlined the key drivers behind that 2026 guidance was reiterated despite a slow start to the year in the first quarter.

You can watch a recording of the presentation here:

Embla Medical - Q1 2026 Event

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR agreement. /Michael Friis 15:00, 03/02/2026.

Sisäänkirjautuminen vaadittu

Tämä sisältö on näkyvissä vain sisäänkirjautuneille käyttäjille

Luo ilmainen tunnus

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Lue lisää yhtiösivulla